Industry Research Reports
Home > Reports > Chemical & Material > Global Mbbr Biomedia and Biochip Market Outlook, In‑Depth Analysis & Forecast to 2032
Global Mbbr Biomedia and Biochip Market Outlook, In‑Depth Analysis & Forecast to 2032
Industry: Chemical & Material
Published Date: 2026-03-12
Pages: 168 Pages
Report ld: 6244513
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Mbbr Biomedia and Biochip Market Size(US$)
CAGR 2026-2032
9.2%
Market Size,2032
USD 24,200
Million
Market Snapshot
Market Size in 2026 (Value)
US$ 14,270 million
Market Forecast in 2032(Value)
US$ 24,200 million
CAGR
9.2%
Years Considered
2021-2032
Base Year
2026
Forecast Period
2026-2032
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Mbbr Biomedia and Biochip market is projected to grow from US$ 13180 million in 2025 to US$ 24200 million by 2032, at a CAGR of 9.2% (2026-2032), driven by critical product segments and diverse end‑use applications.
Mbbr Biomedia (Moving - Bed Biofilm Reactor Biomedia) and biochips are both important concepts in the field of biotechnology, but they have different characteristics and applications.
Mbbr Biomedia is a kind of microbial carrier applied in the MBBR process, mainly providing a suitable growth environment for microorganisms. Usually made of polyethylene, polypropylene and their modified materials, polyurethane foam, etc., its density is close to that of water, and it is mostly cylindrical or spherical. In the aeration tank, it moves freely with the water flow, and the microorganisms grow on its surface to form a bio - film. The collision and shearing action of the carrier in the water make the air bubbles smaller, increasing the utilization rate of oxygen. Moreover, the interior and exterior of each carrier have different types of microorganisms. The interior is anaerobic or anoxic bacteria, and the exterior is aerobic bacteria, which can realize the simultaneous occurrence of nitrification and denitrification reactions. IMbbr Biomedia has the advantages of large specific surface area, good hydrophilicity, high biological activity, fast bio - film formation, etc. It can increase the biomass and types of microorganisms in the reactor, thereby improving the treatment efficiency of the reactor. It is not easy to agglomerate or block, and the bio - film can fall off automatically, without the need for regular back - flushing, and has strong shock - load resistance. Widely used in sewage treatment, it can efficiently remove biological oxygen demand (BOD), chemical oxygen demand (COD), total nitrogen, phosphorus and other pollutants, and is also applicable to pond filters, aquaculture and other fields.
In molecular biology, Biochip is an engineered substrate, also known as a "miniaturized laboratory", which can carry out a large number of biochemical reactions simultaneously. It uses the principle of molecular hybridization, immobilizes a large number of known biological molecules (such as DNA probes, antibodies, etc.) on the chip surface, and makes them hybridize with the labeled sample molecules. Then, it analyzes the biological information of the sample by detecting the hybridization signal. Common biochips include gene chips, protein chips, cell chips, etc. It has the characteristics of high - throughput, miniaturization, and automation, which can realize the rapid and efficient detection and analysis of a large number of biological samples, and has the advantages of high sensitivity and strong specificity. Its application fields are wide, including disease diagnosis, genetic testing, drug screening, biological research, etc. For example, in disease diagnosis, it can quickly detect the presence of specific genes or proteins, helping doctors make a diagnosis.
From a downstream perspective, Laboratory Analysis accounted for % of 2025 revenue, surging to US$ million by 2032 (CAGR: % from 2026–2032).
Mbbr Biomedia and Biochip leading players (including Fresh By Design (FBD), FLI Water Limited, Enke Group, MUTAG A/S, Holly Technology, Pingxiang City ZhongXing Packing, Transcend Cleantec, DST Technology, IWE (Industrial Water Engineers (M) Sdn. Bhd.), Ecologix Environmental Systems, etc.), dominate supply; the top five capture approximately % of global revenue, with Fresh By Design (FBD) leading 2025 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2025 to a forecast US$ million by 2032 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR %), led by China (US$ million in 2025, % share rising to % by 2032), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2032 (CAGR %).
Report Includes:
This definitive report equips business leaders, decision-makers, and stakeholders with a 360° view of the global Mbbr Biomedia and Biochip market across value chain. It analyzes historical revenue data (2021–2025) and delivers forecasts through 2032, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customer distribution pattern.
Granular regional insights cover five major markets (North America, Europe, APAC, South America, and MEA) with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.
Critical competitive intelligence profiles players (revenue, margins, pricing strategies, and major customers) and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise Industry‑chain overview maps upstream, middle stream, and downstream distribution dynamics to identify strategic gaps and unmet demand.
MARKET SEGMENTATION
By Company
- Fresh By Design (FBD)
- FLI Water Limited
- Enke Group
- MUTAG A/S
- Holly Technology
- Pingxiang City ZhongXing Packing
- Transcend Cleantec
- DST Technology
- IWE (Industrial Water Engineers (M) Sdn. Bhd.)
- Ecologix Environmental Systems
- Paras Hydrotech
- bioprocessH2O
- Illumina
- Thermo Fisher Scientific
- Agilent Technologies
- Bio-Rad Laboratories
- PerkinElmer
- BioChain
- Sengenics
- Applied Microarrays
- US Biomax
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Mbbr Biomedia
- Biochip
Segment by Application
- Laboratory Analysis
- Industrial Bioprocessing
- Others
CHAPTER OUTLINE
Chapter 1: Defines the Mbbr Biomedia and Biochip study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential
Chapter 2: Offers current market state, projects global revenue and sales to 2032, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the player landscape: ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves
Chapter 4: Unlocks high margin product segments: compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities: evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application
Chapter 6: North America: breaks down market size by Application and country, profiles key players and assesses growth drivers and barriers
Chapter 7: Europe: analyses regional market by Application and players, flagging drivers and barriers
Chapter 8: Asia Pacific: quantifies market size by Application, and region/country, profiles top players, and uncovers high potential expansion areas
Chapter 9: Central & South America: measures market size by Application, and country, profiles top players, and identifies investment opportunities and challenges
Chapter 10: Middle East and Africa: evaluates market size by Application, and country, profiles key players, and outlines investment prospects and market hurdles
Chapter 11: Profiles players in depth: details product specs, revenue, margins; top-tier players 2025 sales breakdowns by product type, by Application, by region SWOT analysis, and recent strategic developments
Chapter 12: Value chain and ecosystem: analyses upstream, midstream, plus downstream channels
Chapter 13: Market dynamics: explores drivers, restraints, regulatory impacts, and risk mitigation strategies
Chapter 14: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Allocate capital strategically to high growth regions (Chapters 6-10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Introduction to Mbbr Biomedia and Biochip: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Mbbr Biomedia and Biochip Market Size by Type, 2021 vs 2025 vs 2032
1.2.2 Mbbr Biomedia
1.2.3 Biochip
1.3 Market Segmentation by Application
1.3.1 Global Mbbr Biomedia and Biochip Market Size by Application, 2021 vs 2025 vs 2032
1.3.2 Laboratory Analysis
1.3.3 Industrial Bioprocessing
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Mbbr Biomedia and Biochip Revenue Estimates and Forecasts (2021-2032)
2.2 Global Mbbr Biomedia and Biochip Revenue by Region
2.2.1 Revenue Comparison: 2021 vs 2025 vs 2032
2.2.2 Historical and Forecasted Revenue by Region (2021-2032)
2.2.3 Global Revenue-Based Market Share by Region (2021-2032)
2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends
3 Competitive Landscape
3.1 Global Mbbr Biomedia and Biochip Players’ Revenue Rankings and Profitability
3.1.1 Global Revenue (Value) by Players (2021-2026)
3.1.2 Global Key Players’ Revenue Ranking (2024 vs 2025)
3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.1.4 Gross Margin by Top Players (2021 vs 2025)
3.2 Global Mbbr Biomedia and Biochip Companies Headquarters and Service Footprint
3.3 Key Player Market Share by Product Type
3.3.1 Mbbr Biomedia: Market Share by Key Players
3.3.2 Biochip: Market Share by Key Players
3.4 Global Mbbr Biomedia and Biochip Market Concentration and Dynamics
3.4.1 Global Market Concentration
3.4.2 Market Entry and Exit Analysis
3.4.3 Strategic Moves: M&A, Expansion, R&D Investment
4 Product Segmentation
4.1 Global Mbbr Biomedia and Biochip Market by Type
4.1.1 Global Revenue by Type (2021-2032)
4.1.2 Global Revenue-Based Market Share by Type (2021-2032)
4.2 Key Product Attributes and Differentiation
4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.3.1 High-Growth Niches and Adoption Drivers
4.3.2 Profitability Hotspots and Cost Drivers
4.3.3 Substitution Threats
5 Downstream Applications and Customers
5.1 Global Mbbr Biomedia and Biochip Revenue by Application
5.1.1 Global Historical and Forecasted Revenue by Application (2021-2032)
5.1.2 Revenue-Based Market Share by Application (2021-2032)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Downstream Customer Analysis
5.2.1 Top Customers by Region
5.2.2 Top Customers by Application
6 North America
6.1 North America Market Size (2021-2032)
6.2 North America Key Players’ Revenue in 2025
6.3 North America Mbbr Biomedia and Biochip Market Size by Application (2021-2032)
6.4 North America Growth Accelerators and Market Barriers
6.5 North America Mbbr Biomedia and Biochip Market Size by Country
6.5.1 North America Revenue Trends by Country
6.5.2 US
6.5.3 Canada
6.5.4 Mexico
7 Europe
7.1 Europe Market Size (2021-2032)
7.2 Europe Key Players’ Revenue in 2025
7.3 Europe Mbbr Biomedia and Biochip Market Size by Application (2021-2032)
7.4 Europe Growth Accelerators and Market Barriers
7.5 Europe Mbbr Biomedia and Biochip Market Size by Country
7.5.1 Europe Revenue Trends by Country
7.5.2 Germany
7.5.3 France
7.5.4 U.K.
7.5.5 Italy
7.5.6 Russia
8 Asia-Pacific
8.1 Asia-Pacific Market Size (2021-2032)
8.2 Asia-Pacific Key Players’ Revenue in 2025
8.3 Asia-Pacific Mbbr Biomedia and Biochip Market Size by Application (2021-2032)
8.4 Asia-Pacific Growth Accelerators and Market Barriers
8.5 Asia-Pacific Mbbr Biomedia and Biochip Market Size by Region
8.5.1 Asia-Pacific Revenue Trends by Region
8.6 China
8.7 Japan
8.8 South Korea
8.9 Australia
8.10 India
8.11 Southeast Asia
8.11.1 Indonesia
8.11.2 Vietnam
8.11.3 Malaysia
8.11.4 Philippines
8.11.5 Singapore
9 Central and South America
9.1 Central and South America Market Size (2021-2032)
9.2 Central and South America Key Players’ Revenue in 2025
9.3 Central and South America Mbbr Biomedia and Biochip Market Size by Application (2021-2032)
9.4 Central and South America Investment Opportunities and Key Challenges
9.5 Central and South America Mbbr Biomedia and Biochip Market Size by Country
9.5.1 Central and South America Revenue Trends by Country (2021 vs 2025 vs 2032)
9.5.2 Brazil
9.5.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Market Size (2021-2032)
10.2 Middle East and Africa Key Players’ Revenue in 2025
10.3 Middle East and Africa Mbbr Biomedia and Biochip Market Size by Application (2021-2032)
10.4 Middle East and Africa Investment Opportunities and Key Challenges
10.5 Middle East and Africa Mbbr Biomedia and Biochip Market Size by Country
10.5.1 Middle East and Africa Revenue Trends by Country (2021 vs 2025 vs 2032)
10.5.2 GCC Countries
10.5.3 Israel
10.5.4 Egypt
10.5.5 South Africa
11 Corporate Profile
11.1 Fresh By Design (FBD)
11.1.1 Fresh By Design (FBD) Corporation Information
11.1.2 Fresh By Design (FBD) Business Overview
11.1.3 Fresh By Design (FBD) Mbbr Biomedia and Biochip Product Features and Attributes
11.1.4 Fresh By Design (FBD) Mbbr Biomedia and Biochip Revenue and Gross Margin (2021-2026)
11.1.5 Fresh By Design (FBD) Mbbr Biomedia and Biochip Revenue by Product in 2025
11.1.6 Fresh By Design (FBD) Mbbr Biomedia and Biochip Revenue by Application in 2025
11.1.7 Fresh By Design (FBD) Mbbr Biomedia and Biochip Revenue by Geographic Area in 2025
11.1.8 Fresh By Design (FBD) Mbbr Biomedia and Biochip SWOT Analysis
11.1.9 Fresh By Design (FBD) Recent Developments
11.2 FLI Water Limited
11.2.1 FLI Water Limited Corporation Information
11.2.2 FLI Water Limited Business Overview
11.2.3 FLI Water Limited Mbbr Biomedia and Biochip Product Features and Attributes
11.2.4 FLI Water Limited Mbbr Biomedia and Biochip Revenue and Gross Margin (2021-2026)
11.2.5 FLI Water Limited Mbbr Biomedia and Biochip Revenue by Product in 2025
11.2.6 FLI Water Limited Mbbr Biomedia and Biochip Revenue by Application in 2025
11.2.7 FLI Water Limited Mbbr Biomedia and Biochip Revenue by Geographic Area in 2025
11.2.8 FLI Water Limited Mbbr Biomedia and Biochip SWOT Analysis
11.2.9 FLI Water Limited Recent Developments
11.3 Enke Group
11.3.1 Enke Group Corporation Information
11.3.2 Enke Group Business Overview
11.3.3 Enke Group Mbbr Biomedia and Biochip Product Features and Attributes
11.3.4 Enke Group Mbbr Biomedia and Biochip Revenue and Gross Margin (2021-2026)
11.3.5 Enke Group Mbbr Biomedia and Biochip Revenue by Product in 2025
11.3.6 Enke Group Mbbr Biomedia and Biochip Revenue by Application in 2025
11.3.7 Enke Group Mbbr Biomedia and Biochip Revenue by Geographic Area in 2025
11.3.8 Enke Group Mbbr Biomedia and Biochip SWOT Analysis
11.3.9 Enke Group Recent Developments
11.4 MUTAG A/S
11.4.1 MUTAG A/S Corporation Information
11.4.2 MUTAG A/S Business Overview
11.4.3 MUTAG A/S Mbbr Biomedia and Biochip Product Features and Attributes
11.4.4 MUTAG A/S Mbbr Biomedia and Biochip Revenue and Gross Margin (2021-2026)
11.4.5 MUTAG A/S Mbbr Biomedia and Biochip Revenue by Product in 2025
11.4.6 MUTAG A/S Mbbr Biomedia and Biochip Revenue by Application in 2025
11.4.7 MUTAG A/S Mbbr Biomedia and Biochip Revenue by Geographic Area in 2025
11.4.8 MUTAG A/S Mbbr Biomedia and Biochip SWOT Analysis
11.4.9 MUTAG A/S Recent Developments
11.5 Holly Technology
11.5.1 Holly Technology Corporation Information
11.5.2 Holly Technology Business Overview
11.5.3 Holly Technology Mbbr Biomedia and Biochip Product Features and Attributes
11.5.4 Holly Technology Mbbr Biomedia and Biochip Revenue and Gross Margin (2021-2026)
11.5.5 Holly Technology Mbbr Biomedia and Biochip Revenue by Product in 2025
11.5.6 Holly Technology Mbbr Biomedia and Biochip Revenue by Application in 2025
11.5.7 Holly Technology Mbbr Biomedia and Biochip Revenue by Geographic Area in 2025
11.5.8 Holly Technology Mbbr Biomedia and Biochip SWOT Analysis
11.5.9 Holly Technology Recent Developments
11.6 Pingxiang City ZhongXing Packing
11.6.1 Pingxiang City ZhongXing Packing Corporation Information
11.6.2 Pingxiang City ZhongXing Packing Business Overview
11.6.3 Pingxiang City ZhongXing Packing Mbbr Biomedia and Biochip Product Features and Attributes
11.6.4 Pingxiang City ZhongXing Packing Mbbr Biomedia and Biochip Revenue and Gross Margin (2021-2026)
11.6.5 Pingxiang City ZhongXing Packing Recent Developments
11.7 Transcend Cleantec
11.7.1 Transcend Cleantec Corporation Information
11.7.2 Transcend Cleantec Business Overview
11.7.3 Transcend Cleantec Mbbr Biomedia and Biochip Product Features and Attributes
11.7.4 Transcend Cleantec Mbbr Biomedia and Biochip Revenue and Gross Margin (2021-2026)
11.7.5 Transcend Cleantec Recent Developments
11.8 DST Technology
11.8.1 DST Technology Corporation Information
11.8.2 DST Technology Business Overview
11.8.3 DST Technology Mbbr Biomedia and Biochip Product Features and Attributes
11.8.4 DST Technology Mbbr Biomedia and Biochip Revenue and Gross Margin (2021-2026)
11.8.5 DST Technology Recent Developments
11.9 IWE (Industrial Water Engineers (M) Sdn. Bhd.)
11.9.1 IWE (Industrial Water Engineers (M) Sdn. Bhd.) Corporation Information
11.9.2 IWE (Industrial Water Engineers (M) Sdn. Bhd.) Business Overview
11.9.3 IWE (Industrial Water Engineers (M) Sdn. Bhd.) Mbbr Biomedia and Biochip Product Features and Attributes
11.9.4 IWE (Industrial Water Engineers (M) Sdn. Bhd.) Mbbr Biomedia and Biochip Revenue and Gross Margin (2021-2026)
11.9.5 IWE (Industrial Water Engineers (M) Sdn. Bhd.) Recent Developments
11.10 Ecologix Environmental Systems
11.10.1 Ecologix Environmental Systems Corporation Information
11.10.2 Ecologix Environmental Systems Business Overview
11.10.3 Ecologix Environmental Systems Mbbr Biomedia and Biochip Product Features and Attributes
11.10.4 Ecologix Environmental Systems Mbbr Biomedia and Biochip Revenue and Gross Margin (2021-2026)
11.10.5 Company Ten Recent Developments
11.11 Paras Hydrotech
11.11.1 Paras Hydrotech Corporation Information
11.11.2 Paras Hydrotech Business Overview
11.11.3 Paras Hydrotech Mbbr Biomedia and Biochip Product Features and Attributes
11.11.4 Paras Hydrotech Mbbr Biomedia and Biochip Revenue and Gross Margin (2021-2026)
11.11.5 Paras Hydrotech Recent Developments
11.12 bioprocessH2O
11.12.1 bioprocessH2O Corporation Information
11.12.2 bioprocessH2O Business Overview
11.12.3 bioprocessH2O Mbbr Biomedia and Biochip Product Features and Attributes
11.12.4 bioprocessH2O Mbbr Biomedia and Biochip Revenue and Gross Margin (2021-2026)
11.12.5 bioprocessH2O Recent Developments
11.13 Illumina
11.13.1 Illumina Corporation Information
11.13.2 Illumina Business Overview
11.13.3 Illumina Mbbr Biomedia and Biochip Product Features and Attributes
11.13.4 Illumina Mbbr Biomedia and Biochip Revenue and Gross Margin (2021-2026)
11.13.5 Illumina Recent Developments
11.14 Thermo Fisher Scientific
11.14.1 Thermo Fisher Scientific Corporation Information
11.14.2 Thermo Fisher Scientific Business Overview
11.14.3 Thermo Fisher Scientific Mbbr Biomedia and Biochip Product Features and Attributes
11.14.4 Thermo Fisher Scientific Mbbr Biomedia and Biochip Revenue and Gross Margin (2021-2026)
11.14.5 Thermo Fisher Scientific Recent Developments
11.15 Agilent Technologies
11.15.1 Agilent Technologies Corporation Information
11.15.2 Agilent Technologies Business Overview
11.15.3 Agilent Technologies Mbbr Biomedia and Biochip Product Features and Attributes
11.15.4 Agilent Technologies Mbbr Biomedia and Biochip Revenue and Gross Margin (2021-2026)
11.15.5 Agilent Technologies Recent Developments
11.16 Bio-Rad Laboratories
11.16.1 Bio-Rad Laboratories Corporation Information
11.16.2 Bio-Rad Laboratories Business Overview
11.16.3 Bio-Rad Laboratories Mbbr Biomedia and Biochip Product Features and Attributes
11.16.4 Bio-Rad Laboratories Mbbr Biomedia and Biochip Revenue and Gross Margin (2021-2026)
11.16.5 Bio-Rad Laboratories Recent Developments
11.17 PerkinElmer
11.17.1 PerkinElmer Corporation Information
11.17.2 PerkinElmer Business Overview
11.17.3 PerkinElmer Mbbr Biomedia and Biochip Product Features and Attributes
11.17.4 PerkinElmer Mbbr Biomedia and Biochip Revenue and Gross Margin (2021-2026)
11.17.5 PerkinElmer Recent Developments
11.18 BioChain
11.18.1 BioChain Corporation Information
11.18.2 BioChain Business Overview
11.18.3 BioChain Mbbr Biomedia and Biochip Product Features and Attributes
11.18.4 BioChain Mbbr Biomedia and Biochip Revenue and Gross Margin (2021-2026)
11.18.5 BioChain Recent Developments
11.19 Sengenics
11.19.1 Sengenics Corporation Information
11.19.2 Sengenics Business Overview
11.19.3 Sengenics Mbbr Biomedia and Biochip Product Features and Attributes
11.19.4 Sengenics Mbbr Biomedia and Biochip Revenue and Gross Margin (2021-2026)
11.19.5 Sengenics Recent Developments
11.20 Applied Microarrays
11.20.1 Applied Microarrays Corporation Information
11.20.2 Applied Microarrays Business Overview
11.20.3 Applied Microarrays Mbbr Biomedia and Biochip Product Features and Attributes
11.20.4 Applied Microarrays Mbbr Biomedia and Biochip Revenue and Gross Margin (2021-2026)
11.20.5 Applied Microarrays Recent Developments
11.21 US Biomax
11.21.1 US Biomax Corporation Information
11.21.2 US Biomax Business Overview
11.21.3 US Biomax Mbbr Biomedia and Biochip Product Features and Attributes
11.21.4 US Biomax Mbbr Biomedia and Biochip Revenue and Gross Margin (2021-2026)
11.21.5 US Biomax Recent Developments
12 Mbbr Biomedia and Biochip Value Chain and Ecosystem Analysis
12.1 Mbbr Biomedia and Biochip Value Chain (Ecosystem Structure)
12.2 Upstream Analysis
12.2.1 Key Technologies, Platforms and Infrastructure
12.3 Midstream Analysis
12.4 Downstream Sales Model and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Mbbr Biomedia and Biochip Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Mbbr Biomedia and Biochip Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
TABLE OF FIGURES
List of Tables
Table 1. Global Mbbr Biomedia and Biochip Market Size Growth Rate by Type, 2021 vs 2025 vs 2032 (US$ Million)
Table 2. Global Mbbr Biomedia and Biochip Market Size Growth Rate by Application, 2021 vs 2025 vs 2032 (US$ Million)
Table 3. Global Mbbr Biomedia and Biochip Revenue Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 4. Global Mbbr Biomedia and Biochip Revenue by Region (US$ Million), 2021-2026
Table 5. Global Mbbr Biomedia and Biochip Revenue by Region (US$ Million), 2027-2032
Table 6. Emerging Market Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 7. Global Mbbr Biomedia and Biochip Revenue by Players (US$ Million), 2021-2026
Table 8. Global Mbbr Biomedia and Biochip Revenue-Based Market Share by Players (2021-2026)
Table 9. Global Key Players’Ranking Shift (2024 vs 2025) (Based on Revenue)
Table 10. Global Companies by Tier (Tier 1, Tier 2, and Tier 3), based on Mbbr Biomedia and Biochip Revenue, 2025
Table 11. Global Mbbr Biomedia and Biochip Average Gross Margin (%) by Player (2021 vs 2025)
Table 12. Global Mbbr Biomedia and Biochip Companies Headquarters
Table 13. Global Mbbr Biomedia and Biochip Market Concentration Ratio (CR5)
Table 14. Key Market Entrant/Exit (2021-2025) – Drivers & Impact Analysis
Table 15. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 16. Global Mbbr Biomedia and Biochip Revenue by Type (US$ Million), 2021-2026
Table 17. Global Mbbr Biomedia and Biochip Revenue by Type (US$ Million), 2027-2032
Table 18. Key Product Attributes and Differentiation
Table 19. Global Mbbr Biomedia and Biochip Revenue by Application (US$ Million), 2021-2026
Table 20. Global Mbbr Biomedia and Biochip Revenue by Application (US$ Million), 2027-2032
Table 21. Mbbr Biomedia and Biochip High-Growth Sectors Demand CAGR (2026-2032)
Table 22. Top Customers by Region
Table 23. Top Customers by Application
Table 24. North America Mbbr Biomedia and Biochip Growth Accelerators and Market Barriers
Table 25. North America Mbbr Biomedia and Biochip Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 26. Europe Mbbr Biomedia and Biochip Growth Accelerators and Market Barriers
Table 27. Europe Mbbr Biomedia and Biochip Revenue Grow Rate (CAGR) by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 28. Asia-Pacific Mbbr Biomedia and Biochip Growth Accelerators and Market Barriers
Table 29. Asia-Pacific Mbbr Biomedia and Biochip Revenue Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 30. Central and South America Mbbr Biomedia and Biochip Investment Opportunities and Key Challenges
Table 31. Central and South America Mbbr Biomedia and Biochip Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 32. Middle East and Africa Mbbr Biomedia and Biochip Investment Opportunities and Key Challenges
Table 33. Middle East and Africa Mbbr Biomedia and Biochip Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 34. Fresh By Design (FBD) Corporation Information
Table 35. Fresh By Design (FBD) Description and Major Businesses
Table 36. Fresh By Design (FBD) Product Features and Attributes
Table 37. Fresh By Design (FBD) Revenue (US$ Million) and Gross Margin (2021-2026)
Table 38. Fresh By Design (FBD) Revenue Proportion by Product in 2025
Table 39. Fresh By Design (FBD) Revenue Proportion by Application in 2025
Table 40. Fresh By Design (FBD) Revenue Proportion by Geographic Area in 2025
Table 41. Fresh By Design (FBD) Mbbr Biomedia and Biochip SWOT Analysis
Table 42. Fresh By Design (FBD) Recent Developments
Table 43. FLI Water Limited Corporation Information
Table 44. FLI Water Limited Description and Major Businesses
Table 45. FLI Water Limited Product Features and Attributes
Table 46. FLI Water Limited Revenue (US$ Million) and Gross Margin (2021-2026)
Table 47. FLI Water Limited Revenue Proportion by Product in 2025
Table 48. FLI Water Limited Revenue Proportion by Application in 2025
Table 49. FLI Water Limited Revenue Proportion by Geographic Area in 2025
Table 50. FLI Water Limited Mbbr Biomedia and Biochip SWOT Analysis
Table 51. FLI Water Limited Recent Developments
Table 52. Enke Group Corporation Information
Table 53. Enke Group Description and Major Businesses
Table 54. Enke Group Product Features and Attributes
Table 55. Enke Group Revenue (US$ Million) and Gross Margin (2021-2026)
Table 56. Enke Group Revenue Proportion by Product in 2025
Table 57. Enke Group Revenue Proportion by Application in 2025
Table 58. Enke Group Revenue Proportion by Geographic Area in 2025
Table 59. Enke Group Mbbr Biomedia and Biochip SWOT Analysis
Table 60. Enke Group Recent Developments
Table 61. MUTAG A/S Corporation Information
Table 62. MUTAG A/S Description and Major Businesses
Table 63. MUTAG A/S Product Features and Attributes
Table 64. MUTAG A/S Revenue (US$ Million) and Gross Margin (2021-2026)
Table 65. MUTAG A/S Revenue Proportion by Product in 2025
Table 66. MUTAG A/S Revenue Proportion by Application in 2025
Table 67. MUTAG A/S Revenue Proportion by Geographic Area in 2025
Table 68. MUTAG A/S Mbbr Biomedia and Biochip SWOT Analysis
Table 69. MUTAG A/S Recent Developments
Table 70. Holly Technology Corporation Information
Table 71. Holly Technology Description and Major Businesses
Table 72. Holly Technology Product Features and Attributes
Table 73. Holly Technology Revenue (US$ Million) and Gross Margin (2021-2026)
Table 74. Holly Technology Revenue Proportion by Product in 2025
Table 75. Holly Technology Revenue Proportion by Application in 2025
Table 76. Holly Technology Revenue Proportion by Geographic Area in 2025
Table 77. Holly Technology Mbbr Biomedia and Biochip SWOT Analysis
Table 78. Holly Technology Recent Developments
Table 79. Pingxiang City ZhongXing Packing Corporation Information
Table 80. Pingxiang City ZhongXing Packing Description and Major Businesses
Table 81. Pingxiang City ZhongXing Packing Product Features and Attributes
Table 82. Pingxiang City ZhongXing Packing Revenue (US$ Million) and Gross Margin (2021-2026)
Table 83. Pingxiang City ZhongXing Packing Recent Developments
Table 84. Transcend Cleantec Corporation Information
Table 85. Transcend Cleantec Description and Major Businesses
Table 86. Transcend Cleantec Product Features and Attributes
Table 87. Transcend Cleantec Revenue (US$ Million) and Gross Margin (2021-2026)
Table 88. Transcend Cleantec Recent Developments
Table 89. DST Technology Corporation Information
Table 90. DST Technology Description and Major Businesses
Table 91. DST Technology Product Features and Attributes
Table 92. DST Technology Revenue (US$ Million) and Gross Margin (2021-2026)
Table 93. DST Technology Recent Developments
Table 94. IWE (Industrial Water Engineers (M) Sdn. Bhd.) Corporation Information
Table 95. IWE (Industrial Water Engineers (M) Sdn. Bhd.) Description and Major Businesses
Table 96. IWE (Industrial Water Engineers (M) Sdn. Bhd.) Product Features and Attributes
Table 97. IWE (Industrial Water Engineers (M) Sdn. Bhd.) Revenue (US$ Million) and Gross Margin (2021-2026)
Table 98. IWE (Industrial Water Engineers (M) Sdn. Bhd.) Recent Developments
Table 99. Ecologix Environmental Systems Corporation Information
Table 100. Ecologix Environmental Systems Description and Major Businesses
Table 101. Ecologix Environmental Systems Product Features and Attributes
Table 102. Ecologix Environmental Systems Revenue (US$ Million) and Gross Margin (2021-2026)
Table 103. Ecologix Environmental Systems Recent Developments
Table 104. Paras Hydrotech Corporation Information
Table 105. Paras Hydrotech Description and Major Businesses
Table 106. Paras Hydrotech Product Features and Attributes
Table 107. Paras Hydrotech Revenue (US$ Million) and Gross Margin (2021-2026)
Table 108. Paras Hydrotech Recent Developments
Table 109. bioprocessH2O Corporation Information
Table 110. bioprocessH2O Description and Major Businesses
Table 111. bioprocessH2O Product Features and Attributes
Table 112. bioprocessH2O Revenue (US$ Million) and Gross Margin (2021-2026)
Table 113. bioprocessH2O Recent Developments
Table 114. Illumina Corporation Information
Table 115. Illumina Description and Major Businesses
Table 116. Illumina Product Features and Attributes
Table 117. Illumina Revenue (US$ Million) and Gross Margin (2021-2026)
Table 118. Illumina Recent Developments
Table 119. Thermo Fisher Scientific Corporation Information
Table 120. Thermo Fisher Scientific Description and Major Businesses
Table 121. Thermo Fisher Scientific Product Features and Attributes
Table 122. Thermo Fisher Scientific Revenue (US$ Million) and Gross Margin (2021-2026)
Table 123. Thermo Fisher Scientific Recent Developments
Table 124. Agilent Technologies Corporation Information
Table 125. Agilent Technologies Description and Major Businesses
Table 126. Agilent Technologies Product Features and Attributes
Table 127. Agilent Technologies Revenue (US$ Million) and Gross Margin (2021-2026)
Table 128. Agilent Technologies Recent Developments
Table 129. Bio-Rad Laboratories Corporation Information
Table 130. Bio-Rad Laboratories Description and Major Businesses
Table 131. Bio-Rad Laboratories Product Features and Attributes
Table 132. Bio-Rad Laboratories Revenue (US$ Million) and Gross Margin (2021-2026)
Table 133. Bio-Rad Laboratories Recent Developments
Table 134. PerkinElmer Corporation Information
Table 135. PerkinElmer Description and Major Businesses
Table 136. PerkinElmer Product Features and Attributes
Table 137. PerkinElmer Revenue (US$ Million) and Gross Margin (2021-2026)
Table 138. PerkinElmer Recent Developments
Table 139. BioChain Corporation Information
Table 140. BioChain Description and Major Businesses
Table 141. BioChain Product Features and Attributes
Table 142. BioChain Revenue (US$ Million) and Gross Margin (2021-2026)
Table 143. BioChain Recent Developments
Table 144. Sengenics Corporation Information
Table 145. Sengenics Description and Major Businesses
Table 146. Sengenics Product Features and Attributes
Table 147. Sengenics Revenue (US$ Million) and Gross Margin (2021-2026)
Table 148. Sengenics Recent Developments
Table 149. Applied Microarrays Corporation Information
Table 150. Applied Microarrays Description and Major Businesses
Table 151. Applied Microarrays Product Features and Attributes
Table 152. Applied Microarrays Revenue (US$ Million) and Gross Margin (2021-2026)
Table 153. Applied Microarrays Recent Developments
Table 154. US Biomax Corporation Information
Table 155. US Biomax Description and Major Businesses
Table 156. US Biomax Product Features and Attributes
Table 157. US Biomax Revenue (US$ Million) and Gross Margin (2021-2026)
Table 158. US Biomax Recent Developments
Table 159. Technologies, Platforms and Infrastructure
Table 160. Distributors List
Table 161. Market Trends and Market Evolution
Table 162. Market Drivers and Opportunities
Table 163. Market Challenges, Risks, and Restraints
Table 164. Research Programs/Design for This Report
Table 165. Key Data Information from Secondary Sources
Table 166. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Mbbr Biomedia and Biochip Market Size Growth Rate by Type, 2021 vs 2025 vs 2032 (US$ Million)
Figure 2. Mbbr Biomedia Product Picture
Figure 3. Biochip Product Picture
Figure 4. Global Mbbr Biomedia and Biochip Market Size Growth Rate , 2021 vs 2025 vs 2032 (US$ Million)
Figure 5. Global Mbbr Biomedia and Biochip Market Size Growth Rate by Application, 2021 vs 2025 vs 2032 (US$ Million)
Figure 6. Laboratory Analysis
Figure 7. Industrial Bioprocessing
Figure 8. Others
Figure 9. Mbbr Biomedia and Biochip Report Years Considered
Figure 10. Global Mbbr Biomedia and Biochip Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 11. Global Mbbr Biomedia and Biochip Revenue (US$ Million), 2021-2032
Figure 12. Global Mbbr Biomedia and Biochip Revenue (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Figure 13. Global Mbbr Biomedia and Biochip Revenue-Based Market Share by Region (2021-2032)
Figure 14. Global Mbbr Biomedia and Biochip Revenue-Based Market Share Ranking (2025)
Figure 15. Tier Distribution by Revenue Contribution (2021 vs 2025)
Figure 16. Mbbr Biomedia Revenue-Based Market Share by Player in 2025
Figure 17. Biochip Revenue-Based Market Share by Player in 2025
Figure 18. Global Mbbr Biomedia and Biochip Revenue-Based Market Share by Type (2021-2032)
Figure 19. Global Mbbr Biomedia and Biochip Revenue-Based Market Share by Application (2021-2032)
Figure 20. North America Mbbr Biomedia and Biochip Revenue YoY (US$ Million), 2021-2032
Figure 21. North America Top 5 Players Mbbr Biomedia and Biochip Revenue (US$ Million) in 2025
Figure 22. North America Mbbr Biomedia and Biochip Revenue (US$ Million) by Application (2021-2032)
Figure 23. US Mbbr Biomedia and Biochip Revenue (US$ Million), 2021-2032
Figure 24. Canada Mbbr Biomedia and Biochip Revenue (US$ Million), 2021-2032
Figure 25. Mexico Mbbr Biomedia and Biochip Revenue (US$ Million), 2021-2032
Figure 26. Europe Mbbr Biomedia and Biochip Revenue YoY (US$ Million), 2021-2032
Figure 27. Europe Top 5 Players Mbbr Biomedia and Biochip Revenue (US$ Million) in 2025
Figure 28. Europe Mbbr Biomedia and Biochip Revenue (US$ Million) by Application (2021-2032)
Figure 29. Germany Mbbr Biomedia and Biochip Revenue (US$ Million), 2021-2032
Figure 30. France Mbbr Biomedia and Biochip Revenue (US$ Million), 2021-2032
Figure 31. U.K. Mbbr Biomedia and Biochip Revenue (US$ Million), 2021-2032
Figure 32. Italy Mbbr Biomedia and Biochip Revenue (US$ Million), 2021-2032
Figure 33. Russia Mbbr Biomedia and Biochip Revenue (US$ Million), 2021-2032
Figure 34. Asia-Pacific Mbbr Biomedia and Biochip Revenue YoY (US$ Million), 2021-2032
Figure 35. Asia-Pacific Top 8 Players Mbbr Biomedia and Biochip Revenue (US$ Million) in 2025
Figure 36. Asia-Pacific Mbbr Biomedia and Biochip Revenue (US$ Million) by Application (2021-2032)
Figure 37. Indonesia Mbbr Biomedia and Biochip Revenue (US$ Million), 2021-2032
Figure 38. Japan Mbbr Biomedia and Biochip Revenue (US$ Million), 2021-2032
Figure 39. South Korea Mbbr Biomedia and Biochip Revenue (US$ Million), 2021-2032
Figure 40. Australia Mbbr Biomedia and Biochip Revenue (US$ Million), 2021-2032
Figure 41. India Mbbr Biomedia and Biochip Revenue (US$ Million), 2021-2032
Figure 42. Indonesia Mbbr Biomedia and Biochip Revenue (US$ Million), 2021-2032
Figure 43. Vietnam Mbbr Biomedia and Biochip Revenue (US$ Million), 2021-2032
Figure 44. Malaysia Mbbr Biomedia and Biochip Revenue (US$ Million), 2021-2032
Figure 45. Philippines Mbbr Biomedia and Biochip Revenue (US$ Million), 2021-2032
Figure 46. Singapore Mbbr Biomedia and Biochip Revenue (US$ Million), 2021-2032
Figure 47. Central and South America Mbbr Biomedia and Biochip Revenue YoY (US$ Million), 2021-2032
Figure 48. Central and South America Top 5 Players Mbbr Biomedia and Biochip Revenue (US$ Million) in 2025
Figure 49. Central and South America Mbbr Biomedia and Biochip Revenue (US$ Million) by Application (2021-2032)
Figure 50. Brazil Mbbr Biomedia and Biochip Revenue (US$ Million), 2021-2032
Figure 51. Argentina Mbbr Biomedia and Biochip Revenue (US$ Million), 2021-2032
Figure 52. Middle East and Africa Mbbr Biomedia and Biochip Revenue YoY (US$ Million), 2021-2032
Figure 53. Middle East and Africa Top 5 Players Mbbr Biomedia and Biochip Revenue (US$ Million) in 2025
Figure 54. Middle East and Africa Mbbr Biomedia and Biochip Revenue (US$ Million) by Application (2021-2032)
Figure 55. GCC Countries Mbbr Biomedia and Biochip Revenue (US$ Million), 2021-2032
Figure 56. Israel Mbbr Biomedia and Biochip Revenue (US$ Million), 2021-2032
Figure 57. Egypt Mbbr Biomedia and Biochip Revenue (US$ Million), 2021-2032
Figure 58. South Africa Mbbr Biomedia and Biochip Revenue (US$ Million), 2021-2032
Figure 59. Mbbr Biomedia and Biochip Value Chain Mapping
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
Which region is expected to have the highest market share?
For each regional market, the report conducted in-depth comparative analysis from multiple dimensions such as market size, 9.2% compound annual growth rate, market demand, industrial structure, policy environment, and the layout of major enterprises. It systematically summarized the market characteristics and competitive environment of different regions. At the same time, it also focused on analyzing the demand structure, market growth drivers, and investment environment of each region, providing valuable references for enterprises to identify key regional markets, formulate global market layouts and sales strategies.
What was the global market size of Mbbr Biomedia and Biochip in 2032?
What was the global market size of Mbbr Biomedia and Biochip in 2026?
What is the annual compound growth rate of the global Mbbr Biomedia and Biochip market size from 2026 to 2032?
Which companies rank high in the global Mbbr Biomedia and Biochip market?
Related Reports
Global Mbbr Biomedia and Biochip Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Mbbr Biomedia and Biochip market size was US$ 13180 million in 2025 and is forecast to reach a readjusted size of US$ 24200 million by 2032 with a CAGR of 9.2% during the forecast period 2026-2032.
Published Date: 2026-03-12
Pages: 113
USD 4250.00
(Single User License)
Global Mbbr Biomedia and Biochip Market Research Report 2026
The global Mbbr Biomedia and Biochip market was valued at US$ 13180 million in 2025 and is anticipated to reach US$ 24200 million by 2032, at a CAGR of 9.2% from 2026 to 2032.
Published Date: 2026-03-12
Pages: 149
USD 2900.00
(Single User License)
Mbbr Biomedia and Biochip - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Mbbr Biomedia and Biochip was estimated to be worth US$ 13180 million in 2025 and is projected to reach US$ 24200 million, growing at a CAGR of 9.2% from 2026 to 2032.
Published Date: 2026-03-09
Pages: 158
USD 3950.00
(Single User License)
Mbbr Biomedia and Biochip - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Mbbr Biomedia and Biochip was estimated to be worth US$ 12074 million in 2024 and is forecast to a readjusted size of US$ 22352 million by 2031 with a CAGR of 9.2% during the forecast period 2025-2031.
Published Date: 2025-08-02
Pages: 143
USD 3950.00
(Single User License)
Global Mbbr Biomedia and Biochip Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Mbbr Biomedia and Biochip market size was US$ 12074 million in 2024 and is forecast to a readjusted size of US$ 22352 million by 2031 with a CAGR of 9.2% during the forecast period 2025-2031.
Published Date: 2025-08-02
Pages: 117
USD 4250.00
(Single User License)
Global Mbbr Biomedia and Biochip Market Research Report 2025
The global market for Mbbr Biomedia and Biochip was valued at US$ 12074 million in the year 2024 and is projected to reach a revised size of US$ 22352 million by 2031, growing at a CAGR of 9.2% during the forecast period.
Published Date: 2025-08-02
Pages: 102
USD 2900.00
(Single User License)
Global Mbbr Biomedia and Biochip Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Mbbr Biomedia and Biochip market is projected to grow from US$ 12074 million in 2024 to US$ 22352 million by 2031, at a CAGR of 9.2% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-08-02
Pages: 174
USD 4900.00
(Single User License)
Global Mbbr Biomedia and Biochip Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Mbbr Biomedia and Biochip market size was US$ 13180 million in 2025 and is forecast to reach a readjusted size of US$ 24200 million by 2032 with a CAGR of 9.2% during the forecast period 2026-2032.
Published: 2026-03-12
Pages: 113
USD 4250.00 (Single User License)Global Mbbr Biomedia and Biochip Market Research Report 2026
The global Mbbr Biomedia and Biochip market was valued at US$ 13180 million in 2025 and is anticipated to reach US$ 24200 million by 2032, at a CAGR of 9.2% from 2026 to 2032.
Published: 2026-03-12
Pages: 149
USD 2900.00 (Single User License)Mbbr Biomedia and Biochip - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Mbbr Biomedia and Biochip was estimated to be worth US$ 13180 million in 2025 and is projected to reach US$ 24200 million, growing at a CAGR of 9.2% from 2026 to 2032.
Published: 2026-03-09
Pages: 158
USD 3950.00 (Single User License)Mbbr Biomedia and Biochip - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Mbbr Biomedia and Biochip was estimated to be worth US$ 12074 million in 2024 and is forecast to a readjusted size of US$ 22352 million by 2031 with a CAGR of 9.2% during the forecast period 2025-2031.
Published: 2025-08-02
Pages: 143
USD 3950.00 (Single User License)Global Mbbr Biomedia and Biochip Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Mbbr Biomedia and Biochip market size was US$ 12074 million in 2024 and is forecast to a readjusted size of US$ 22352 million by 2031 with a CAGR of 9.2% during the forecast period 2025-2031.
Published: 2025-08-02
Pages: 117
USD 4250.00 (Single User License)Global Mbbr Biomedia and Biochip Market Research Report 2025
The global market for Mbbr Biomedia and Biochip was valued at US$ 12074 million in the year 2024 and is projected to reach a revised size of US$ 22352 million by 2031, growing at a CAGR of 9.2% during the forecast period.
Published: 2025-08-02
Pages: 102
USD 2900.00 (Single User License)Global Mbbr Biomedia and Biochip Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Mbbr Biomedia and Biochip market is projected to grow from US$ 12074 million in 2024 to US$ 22352 million by 2031, at a CAGR of 9.2% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-08-02
Pages: 174
USD 4900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 4900.00
USD 7350.00
USD 9800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now